Biden on drug costs: 'Even if you think this doesn't affect you, it does'

President Biden on Monday discussed the burden of prescription drug prices in America, and how his House-passed Build Back Better bill aims to ease some of those tensions.

"It will not surprise you to know that we pay the highest prescription drug prices of any developed nation in the world," the president lamented. "Even if you think this doesn't affect you, it does. Everyone has less money in their pockets because high drug costs make health insurance more expensive for everyone."

"Prescription drugs are outrageously expensive in this country," Biden went on, "doesn't need to be that way." And "under my Build Back Better bill ... it won't be the same way."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
See more

The president then discussed, as an example, how his legislation will impact insulin prices and "lower the cost of families dealing with diabetes."

See more

Biden concluded by explaining that the cost of prescription drugs is "not a partisan issue," because diabetes, Alzheimer's, cancer, or any other disease "don't care if you're a Democrat or a Republican."

See more

Watch his full remarks below:

See more
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Brigid Kennedy

Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.